NewIcon logo

NewIcon

NewIcon is a Finnish maker of hospital and pharmacy automation, including the IV ICON compounding system for intravenous antibiotics, automated dispensing systems, and dispensing cabinets. Revenue was 4.4 million euros in 2025, an estimated $5.0 million, with an operating loss.5,2,3

Robotics Reviewed Editorial TeamUpdated November 12, 2026newicon.fi

Our take

NewIcon builds compounding robots that prepare intravenous antibiotic doses, plus automated dispensing systems for pharmacies and dispensing cabinets for hospital wards. Its compounding systems prepare up to 500,000 doses a year.2,3

It suits hospital pharmacies, mainly in the Nordics, that want to automate antibiotic preparation. Buyers should weigh its small size and weak balance sheet.5

Scores by criterion

NewIcon scores out of 10
Pricing transparency3.0
Product maturity6.5
Deployment evidence6.0
Company durability3.5
Ease of integration6.0
Overall score (average of the five)5.0

Pricing transparency, 3.0: NewIcon publishes no prices for its systems.2

Product maturity, 6.5: It delivered its first automated dispensing system in 2008 and its first compounding system for intravenous antibiotics in 2015.3

Deployment evidence, 6.0: It has delivered systems in Finland, Denmark, Russia, Israel, Iran, and China, including what it calls the world's largest automated dispensing system at HUS Pharmacy in 2016.3

Company durability, 3.5: Revenue was 4.4 million euros in 2025, up 4.6 percent, with an operating margin of minus 10.9 percent and negative equity, according to Finnish credit records.5

Ease of integration, 6.0: The compounding systems are designed for hospital pharmacy clean rooms, and the cabinets and dispensing systems connect to the pharmacy's medication workflow.2,1

Each criterion is defined on our methodology page.

Who uses NewIcon and what it's for

The buyer is a hospital pharmacy that wants to automate the preparation of intravenous antibiotic doses or automate dispensing.2

Buyers should compare it with ARxIUM, EQUASHIELD Pro, KIRO Oncology, Omnicell, and Loccioni.

Compounding and dispensing

The IV ICON system prepares ready-to-administer intravenous antibiotic doses in hospital pharmacies. NewIcon also makes automated dispensing systems for pharmacies and dispensing cabinets for wards.2,1

Deployments

NewIcon entered Russia in 2012, Israel in 2015, Iran and China in 2016, and Denmark in 2017. In 2018 it set up a joint venture with a Shanghai health IT company.3

Pricing

NewIcon does not publish prices.2

Company, ownership, and revenue

Ossi Parviainen founded the company in 2007 and is chief executive officer. It raised 4.4 million euros in a crowdfunded share issue in 2017 and 4.5 million euros from Highlight Health Investment in 2018.3,4

Revenue was 4.4 million euros in 2025 with 37 employees.5

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for5.06.46.16.76.7
NewIcon and its competitors
CompanyProductPricing modelDeployment footprintWhere NewIcon wins or loses
NewIconIV ICON compounding for intravenous antibiotics, dispensing systems and cabinets2Not published2Hospitals and pharmacies in six countries, mainly Finland3Finnish IV compounding maker; small and loss-making
ARxIUMRIVA IV robot plus packagers, cabinets, and inventory software6Not published; consultation16More than 19 million RIVA doses7ARxIUM wins on one vendor for IV robots and wider pharmacy automation. NewIcon wins on intravenous antibiotic compounding at a small vendor.
EQUASHIELD ProAutomated hazardous drug compounder using closed transfer devices9Not published; quote9Equashield sells on five continents10EQUASHIELD wins on closed transfer protection from start to finish. NewIcon wins on intravenous antibiotic compounding at a small vendor.
KIRO OncologyTwo-arm hazardous drug compounder with gravimetric checks11Not published; quote11Part of the inclusiv IV compounding portfolio17KIRO wins on gravimetric checks and self-cleaning. NewIcon wins on intravenous antibiotic compounding at a small vendor.
OmnicellIVX Station robot inside the IV Compounding Service14Not published; service model14Hospitals, clinics, and care settings13Omnicell wins on a managed IV compounding service. NewIcon wins on intravenous antibiotic compounding at a small vendor.
Loccioni APOTECAchemoAPOTECAchemo IV chemotherapy compounding robot15Not published15User community across the US, Europe, the Gulf, and Asia15Loccioni wins on an established chemo compounding user community. NewIcon wins on intravenous antibiotic compounding at a small vendor.

Limits

Operating losses and negative equity.5

No published prices.2

Small team of 37 people.5

What customers say

Where it helps

Automated intravenous antibiotic compounding for hospital pharmacies.2

Where it falls short

Weak balance sheet.5

Leadership

Sources